A Study to Assess the Tolerability of Oxylanthanum Carbonate in Patients With Chronic Kidney Disease on Dialysis

NCT06218290 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Kidney Disease Requiring Chronic Dialysis

Interventions

DRUG: Oxylanthanum Carbonate

Sponsor

Unicycive Therapeutics, Inc